01/06/2021
HOUSTON, TEXAS - January 05, 2021 – C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American:
11/24/2020
Studies Demonstrate Impact of Proprietary Isotope on Prostate and Brain Cancers At World’s Premier Radiation ...
11/10/2020
Revenue Increased 3% Year-Over-Year
Non-Prostate Brachytherapy Revenue Increased 104% Year-Over-Year
RICHLAND, ...
11/02/2020
Conference Call is Tuesday, November 10, 2020 at 4:30 p.m. ET/1:30 p.m. P
RICHLAND, WASHINGTON – November 2, ...
10/20/2020
RICHLAND, Wash., October 20, 2020 - Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator ...
10/19/2020
RICHLAND, Wash., October 19, 2020 -- Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical ...
09/17/2020
Record Full Year Revenue and Gross Profit
Full Year Revenue Increased 32% Year-Over-Year
RICHLAND, WASHINGTON – ...
09/16/2020
RICHLAND, WASHINGTON – September 16, 2020 – Isoray, Inc. (NYSE American: ISR), a medical technology company and ...
09/10/2020
Conference Call is Thursday, September 17, 2020, at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September ...
06/17/2020
Trial Will Evaluate Use of Pembrolizumab, Known as Keytruda®*, With Cesium-131 and Surgical Resection RICHLAND, ...
06/02/2020
RICHLAND, WASHINGTON – June 2, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the results of a new ...
05/12/2020
RICHLAND, WASHINGTON – May 12, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the Centers for ...
[dsm_card title=”Media & Public Relations Contact” button_url_new_window=”1″ _builder_version=”4.8.1″ _module_preset=”default” background_color=”#FFFFFF” custom_margin=”||0px||false|false” hover_enabled=”0″ sticky_enabled=”0″]
If you have questions or need help, please contact:
Chuck Padala
Public and Media Relations
[/dsm_card]